Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)114-126
JournalDrug Resistance Updates
Volume12
Issue number4-5
DOIs
Publication statusPublished - 2009

Cite this

@article{2a552f1e996e4579918130c6d5b7bd34,
title = "Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib",
author = "H.J. Broxterman and K.J. Gotink and H.M.W. Verheul",
year = "2009",
doi = "10.1016/j.drup.2009.07.001",
language = "Undefined/Unknown",
volume = "12",
pages = "114--126",
journal = "Drug Resistance Updates",
issn = "1368-7646",
publisher = "Churchill Livingstone",
number = "4-5",

}

Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib. / Broxterman, H.J.; Gotink, K.J.; Verheul, H.M.W.

In: Drug Resistance Updates, Vol. 12, No. 4-5, 2009, p. 114-126.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib

AU - Broxterman, H.J.

AU - Gotink, K.J.

AU - Verheul, H.M.W.

PY - 2009

Y1 - 2009

U2 - 10.1016/j.drup.2009.07.001

DO - 10.1016/j.drup.2009.07.001

M3 - Article

VL - 12

SP - 114

EP - 126

JO - Drug Resistance Updates

JF - Drug Resistance Updates

SN - 1368-7646

IS - 4-5

ER -